DERM YTD ReturnDermira YTD Return




The DERM YTD return is -4.28% with dividends reinvested through 09/14/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.

This page shows DERM YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.

Quick links: YTD Return Table  |  Performance Chart  |  Peers
Start date: 12/31/2025
End date: 09/14/2026
Start price/share: $7.71
End price/share: $7.38
Dividends collected/share: $0.00
DERM YTD return: -4.28%
Annualized Gain: -6.10%
Starting investment: $10,000.00
Ending investment: $9,572.00
Years: 0.70


DERM YTD return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare DERM YTD return (see YTD Return Formula; YTD Return vs Yield) versus benchmarks:

YTD Return on S&P
YTD Return on Dow
YTD Return on Nasdaq 100
YTD Return on Russell 2000
YTD Return on Gold
YTD Return on 10 Year Treasury
YTD Return on $10,000.00
Without Dividends Reinvested Into DERM


Also see: DERM Average Annual Return
Journey Medical Corporation is a commercial-stage pharmaceutical company. Co. is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes seven branded and two authorized generic prescription drugs for dermatological conditions that are marketed in the U.S.. Its marketed products, which have been approved by the U.S. Food and Drug Administration (FDA) for sale, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox and Luxamend. It sells two authorized generic products, including sulconazole nitrate cream and solution and doxycycline hyclate immediate release 50mg tablets. The DERM YTD return is shown above.

The YTD Return on the DERM YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis.

Thus, researching Year-To-Date Returns is good practice for investors — whether DERM YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the DERM YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns.
Quotes delayed 20 minutes

Email EnvelopeFree DERM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in YTD Return!
Dermira (DERM) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:

DFFN YTD Return
DGX YTD Return
DHR YTD Return
DICE YTD Return
DMK YTD Return
DMPI YTD Return
DMRA YTD Return
DMTK YTD Return
DNAY YTD Return
DNLI YTD Return
More Healthcare companies »
 

DERM YTD Return | www.YTDReturn.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in YTDReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.